<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>0</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Huang,Guosheng</AUTHOR>
		<AUTHOR>Eisenberg,Rosana</AUTHOR>
		<AUTHOR>Yan,Min</AUTHOR>
		<AUTHOR>Monti,Stefano</AUTHOR>
		<AUTHOR>Lawrence,Earl</AUTHOR>
		<AUTHOR>Fu,Pingfu</AUTHOR>
		<AUTHOR>Walbroehl,Jaclyn</AUTHOR>
		<AUTHOR>L</AUTHOR>
	</AUTHORS>
	<YEAR>2008</YEAR>
	<TITLE>15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer</TITLE>
	<SECONDARY_TITLE>Cancer Research</SECONDARY_TITLE>
	<VOLUME>68</VOLUME>
	<NUMBER>13</NUMBER>
	<PAGES>5040 - 8</PAGES>
	<DATE>2008/07/01/</DATE>
	<ISBN>1538-7445</ISBN>
	<KEYWORDS>
		<KEYWORD>Adenocarcinoma,</KEYWORD>
		<KEYWORD>Animals,</KEYWORD>
		<KEYWORD>Base</KEYWORD>
		<KEYWORD>Sequence,</KEYWORD>
		<KEYWORD>Binding</KEYWORD>
		<KEYWORD>Sites,</KEYWORD>
		<KEYWORD>Down-Regulation,</KEYWORD>
		<KEYWORD>Gene</KEYWORD>
		<KEYWORD>Expression</KEYWORD>
		<KEYWORD>Profiling,</KEYWORD>
		<KEYWORD>Gene</KEYWORD>
		<KEYWORD>Expression</KEYWORD>
		<KEYWORD>Regulation,</KEYWORD>
		<KEYWORD>Enzymologic,</KEYWORD>
		<KEYWORD>Gene</KEYWORD>
		<KEYWORD>Expression</KEYWORD>
		<KEYWORD>Regulation,</KEYWORD>
		<KEYWORD>Neoplastic,</KEYWORD>
		<KEYWORD>Genes,</KEYWORD>
		<KEYWORD>Tumor</KEYWORD>
		<KEYWORD>Suppressor,</KEYWORD>
		<KEYWORD>Hepatocyte</KEYWORD>
		<KEYWORD>Nuclear</KEYWORD>
		<KEYWORD>Factor</KEYWORD>
		<KEYWORD>3-beta,</KEYWORD>
		<KEYWORD>Humans,</KEYWORD>
		<KEYWORD>Hydroxyp</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>The forkhead transcription factor hepatocyte nuclear factor 3beta (HNF3beta) is essential in foregut development and the regulation of lung-specific genes. HNF3beta expression leads to growth arrest and apoptosis in lung cancer cells and HNF3beta is a candidate tumor suppressor in lung cancer. In a transcriptional profiling study using a conditional cell line system, we now identify 15-PGDH as one of the major genes induced by HNF3beta expression. 15-PGDH is a critical metabolic enzyme of proliferative prostaglandins, an antagonist to cyclooxygenase-2 and a tumor suppressor in colon cancer. We confirmed the regulation of 15-PGDH expression by HNF3beta in a number of systems and showed direct binding of HNF3beta to 15-PGDH promoter elements. Western blotting of lung cancer cell lines and immunohistochemical examination of human lung cancer tissues found loss of 15-PGDH expression in approximately 65% of lung cancers. Further studies using in vitro cell-based assays and in vivo xenograft tumorigenesis assays showed a lack of in vitro but significant in vivo tumor suppressor activity of 15-PGDH via an antiangiogenic mechanism analogous to its role in colon cancer. In summary, we identify 15-PGDH as a direct downstream effector of HNF3beta and show that 15-PGDH acts as a tumor suppressor in lung cancer.</ABSTRACT>
	<URL>http://www.ncbi.nlm.nih.gov/pubmed/18593902</URL>
</RECORD>
</RECORDS></XML>